4-(氯甲酰基)苯基甲基碳酸酯 | 78152-12-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-(氯甲酰基)苯基甲基碳酸酯
• 英文名称: 4-methoxycarbonyloxybenzoyl chloride
• 英文别名: 4-methoxycarbonyloxy-benzoyl chloride；4-Methoxycarbonyloxy-benzoylchlorid；(4-Oxy-benzoylchlorid)-O-(carbonsaeure-methylester)；4-(Carbomethoxy-oxy)-benzoylchlorid；4-Carbomethoxy-oxybenzoylchlorid；4-(Chlorocarbonyl)phenyl methyl carbonate；(4-carbonochloridoylphenyl) methyl carbonate
• CAS: 78152-12-2
• 化学式: C₉H₇ClO₄
• 分子量: 214.605
• InChiKey: LNOGRKDHGJQANU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  52.6
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 海关编码：
  2920909090

反应信息

• 作为反应物：
  描述：

  4-(氯甲酰基)苯基甲基碳酸酯 在 吡啶 、 4-二甲氨基吡啶 、 氨 作用下， 以 乙醇 为溶剂， 反应 6.0h， 生成 4-n-heptyloxyphenyl 4-hydroxybenzoate
  参考文献：
  名称：

  Chin, E.; Goodby, J. W., Molecular Crystals and Liquid Crystals (1969-1991), 1986, vol. 141, p. 311 - 320

  摘要：

  DOI：
• 作为产物：
  描述：

  对羟基苯甲酸 在 sodium hydroxide 、 五氯化磷 作用下， 生成 4-(氯甲酰基)苯基甲基碳酸酯
  参考文献：
  名称：

  Fischer,E., Chemische Berichte, 1908, vol. 41, p. 2872

  摘要：

  DOI：

文献信息

• Synthesis of deuterium-labelled, optically active, ferroelectric liquid crystals
  作者：A. Marini、V. Domenici、C. Malanga、R. Menicagli、C.A. Veracini

  DOI：10.1016/j.tet.2010.03.025

  日期：2010.5

  The synthesis of two selectively deuterium-labelled 4-(((S)-1-((S)-1-((S)-2-methylbutoxy)-1-oxopropan-2-yloxy)-1-oxopropan-2-yloxy)carbonyl)phenyl 4′-(heptyloxy)biphenyl-4-carboxylate derivatives is reported. A new preparation strategy was developed in order to optimise the yields as well as the optical purity, this property being of fundamental importance for the optical applications of this ferroelectric

  两种选择性氘标记的4-（（（S）-1-（（S））-1-（（S）-2-methylbutoxy）-1-oxopropan-2-yloxy）-1-oxopropan-2-的合成据报道，烷氧基）羰基）苯基4'-（庚氧基）联苯-4-羧酸酯衍生物。为了优化产率和光学纯度，开发了一种新的制备策略，该性质对于该铁电液晶的光学应用至关重要。
• Formation of columnar hexagonal mesophases near room temperature from functionalised [9]aneNS2 (1,4-dithia-7-azacyclononane)
  作者：Alexander J. Blake、Duncan W. Bruce、Jonathan P. Danks、Ian A. Fallis、Daniel Guillon、Steven A. Ross、Heiko Richtzenhain、Martin Schröder

  DOI：10.1039/b006753i

  日期：——

  Oligo(benzoate) derivatives, (R)[9]aneNS2, of 1,4-dithia-7-azacyclononane [R = OC-C6H4-4-OR′ (1) [R′ = C3H7 (a) C8H17 (b)], OC-C6H4-4-O2C-C6H4-4-OC8H17 (2), OC-C6H4-4-O2C-C6H4-4-O2C-Z, Z = C6H4-4-OC8H17 (3), C6H3-3,4-(OR′2)2 (4) [R′ = C4H9 (a), C8H17 (b), C12H25 (c)], C6H2-3,4,5-(OC12H25)3 (5)] have been synthesised. Compound 3 displays monotropic nematic and smectic phases, while 5 shows an enantiotropic columnar hexagonal phase (Colh) just above room temperature as characterised by X-ray scattering experiments. Dilatometry suggests a model for the packing of molecules of 5 in the mesophase. An alternative route to these compounds has been developed via the preparation of the protected species 6 [R = OC-C6H4-4-OC(O)OMe], which can be deprotected using aqueous NH3 to give 7 [R = OC-C6H4-4-OH], followed by reaction with the appropriate acid chloride or anhydride. Oligo(benzoate) derivatives, (R)2[9]aneN2S, of 1-thia-4,7-diazacyclononane [R = OC-C6H4-4-OC(O)OMe (8), OC-C6H4-4-OH (9) OC-C6H4-4-O2C-C6H4-4-OC8H17 (10), OC-C6H4-4-O2C-C6H2-3,4,5-(OC12H25)3 (11)] have been prepared as transesterification products.

  寡（苯甲酸酯）衍生物，（R）[9]aneNS2，的1,4-二硫-7-氮杂环壬烷[R = OC-C6H4-4-OR′（1）[R′ = C3H7（a）C8H17（b）]，OC-C6H4-4-O2C-C6H4-4-OC8H17（2），OC-C6H4-4-O2C-C6H4-4-O2C-Z，Z = C6H4-4-OC8H17（3），C6H3-3,4-（OR′2）2（4）[R′ = C4H9（a），C8H17（b），C12H25（c）]，C6H2-3,4,5-（OC12H25）3（5）]已经合成。化合物3显示出单向性的向列相和层状相，而5则在室温以上显示出对映各向异性的六角柱状相（Colh），这一特性通过X射线散射实验得到了表征。膨胀测定法提出了一种模型，用于描述5在介相中分子的堆积方式。通过制备保护性物种6[R = OC-C6H4-4-OC（O）OMe]，然后使用氨水去保护得到7[R = OC-C6H4-4-OH]，再与适当的酰氯或酸酐反应，开发了一种制备这些化合物的替代路线。寡（苯甲酸酯）衍生物，（R）2[9]aneN2S，的1-硫-4,7-二氮杂环壬烷[R = OC-C6H4-4-OC（O）OMe（8），OC-C6H4-4-OH（9）OC-C6H4-4-O2C-C6H4-4-OC8H17（10），OC-C6H4-4-O2C-C6H2-3,4,5-（OC12H25）3（11）]已经作为转酯化产物制备。
• Structure of carbosilane amphiphilic liquid-crystalline codendrimers in bulk and in thin (Langmuir) films
  作者：I. D. Leshchiner、E. V. Agina、N. I. Boiko、R. Richardson、V. P. Shibaev

  DOI：10.1007/s11172-008-0285-3

  日期：2008.10

  Amphiphilic carbosilane liquid-crystalline codendrimers with terminal mesogenic butoxybenzoate and phenolic groups have been synthesized for the first time. The structures and compositions of the synthesized codendrimers were characterized by NMR spectroscopy. The data from polarization optical microscopy, differential scanning calorimetry, and small-angle X-ray scattering demonstrated that all codendrimers

  首次合成了具有末端介晶丁氧基苯甲酸酯和酚基的两亲碳硅烷液晶共聚合物。合成的共聚合物的结构和组成通过核磁共振光谱表征。来自偏振光学显微镜、差示扫描量热法和小角度 X 射线散射的数据表明，所有的共聚体都具有介晶特性。它们在水-空气界面形成薄（朗缪尔）薄膜。绘制了表面压力-表面积等温线。不同厚度的Langmuir-Blodgett薄膜是通过垂直浸渍法在固体基底上获得的。通过掠入射X射线衍射分析研究膜结构。
• Novel prostaglandin compounds, processes for the preparation thereof and pharmaceutical compositions containing them
  申请人：AMERICAN CYANAMID COMPANY

  公开号：EP0002590A1

  公开（公告）日：1979-06-27

  The invention provides novel prostaglandin compounds and processes for the preparation thereof which are prostaglandins of the E, F, or A series having on the terminal methylene carbon of the alpha chain a substituent selected from the group consisting of wherein R is an alkyl group and R15 is C1-C4 alkyl, di-C1-C4- alkylamino and phenyl or phenyl substituted with one or more substituents selected from the group consisting of C1-C4 alkyl, OR, SR, F or C1 wherein R is as previously defined. Processes for the preparation of these compounds are described as well as pharmaceutical compositions containing them. The compounds have a potential utility in medicine as for example: hypotensive agents, anti-ulcer agents and bronchodilators.

  本发明提供了新型前列腺素化合物及其制备方法，这些化合物是 E、F 或 A 系列的前列腺素，其 α 链的末端亚甲基碳上有一个从以下组中选出的取代基：其中 R 是烷基，R15 是 C1-C4 烷基、二 C1-C4 烷基氨基和苯基或被一个或多个从以下组中选出的取代基取代的苯基，这些组包括 C1-C4 烷基、OR、SR、F 或 C1，其中 R 如前所定义。 本发明描述了这些化合物的制备方法以及含有这些化合物的药物组合物。 这些化合物在医药方面具有潜在的用途，例如：降血压剂、抗溃疡剂和支气管扩张剂。
• 16-Hydroxy-16-vinyl (or cyclopropyl)-prostan-1-ols and pharmaceutical compositions containing the same
  申请人：AMERICAN CYANAMID COMPANY

  公开号：EP0013107A1

  公开（公告）日：1980-07-09

  There are disclosed novel 15-deoxy-16-hydroxy-16- substituted prostanoic acid analogs in which the C-1 carboxyl is replaced by a primary alcohol and carboxylic acid esters, carbonates and carbamates thereof, and which have utility as bronchodilators, as hypotensive agents, and as agents forthe control of excessive gastric secretion. The novel compounds are represented by the formula: wherein Q is a divalent cyclopentyl moiety selected from the group consisting of: wherein R/ is an alkyl (C3-C7) optionally substituted with one or more alkyl groups of one to three carbon atoms; R2 is selected from the group hydroxyl, alkoxyl, alkanoyloxy, a protecting group such as tetrahydropyran-2-yl-oxy, triloweralkylsilyloxy; or alkoxyalkoxy such as wherein R' is hydrogen or alkyl (C1-C4) and R" is alkyl (C1-C4); X is the divalent radical wherein R3 is selected from the group vinyl and cyclopropyl; Z is selected from the group -(CH2)4, cis and and W is selected from the group consisting of -(CH2)3 OH and wherein R4 is selected from the group alkyl (C,-C.); alkoxy (C1-C4); dialkylamino (C1-C4); phenyl and phenyl substituted with one or more substituents selected from the group consisting of hydrogen, hydroxyl, lower alkyl, lower alkoxy, loweralkylthia, fluoride or chloride, wherein lower alkyl is C1-C4; The formula above embraces the optical isomers, racemic or other mixtures of these isomers and the mirror images thereof

  公开了新型 15-脱氧-16-羟基-16-取代的前列酸类似物，其中 C-1 羧基被伯醇及其羧酸酯、碳酸酯和氨基甲酸酯取代，可用作支气管扩张剂、降压药和控制胃分泌过多的药物。这些新型化合物由式表示： 其中 Q 是二价环戊基，选自由以下组成的组： 其中 R/ 是任选被一个或多个一至三个碳原子的烷基取代的烷基（C3-C7）；R2 选自羟基、烷氧基、烷酰氧基、保护基团如四氢吡喃-2-基氧基、三烷基硅氧基；或烷氧基烷氧基，如 其中 R' 为氢或烷基（C1-C4），R" 为烷基（C1-C4）； X 为二价基 其中 R3 选自乙烯基和环丙基组； Z 选自-(CH2)4 组，顺式和逆式。 和 W 选自-(CH2)3 OH 和-(CH2)4-OH 所组成的组。 其中 R4 选自烷基（C,-C.）；烷氧基（C1-C4）；二烷基氨基（C1-C4）；苯基和被一个或多个取代基取代的苯基，取代基选自氢、羟基、低级烷基、低级烷氧基、低级烷硫基、氟化物或氯化物组成的组，其中低级烷基为 C1-C4； 上式包括这些异构体的光学异构体、外消旋体或其他混合物及其镜像。